Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug developmentHUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop instrumentationOrganoids provide drug response data earlier in the development process while helping to maintain project scale
Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding B.V. (HUB) following regulatory clearances and the fulfilment of other customary closing conditions. The acquisition, which closed on December 23, 2024, is a strategic step aligned with the company’s commitment to providing novel next-generation biology solutions to the life science industry, specifically by enabling wider access to HUB’s technology for more faster and more effective drug development. Terms of the deal were not disclosed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250106594037/en/
Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)
“The use of organoids offers tremendous potential to improve the drug discovery process,” said Jean-Charles Wirth, Head of Science and Lab Solutions, Life Science business of Merck. “HUB’s advanced technology, combined with our cell culture expertise and broad portfolio, makes us a valuable resource for researchers looking to leverage the power of 3D cell culture to understand the impact of drug response earlier in the development process.”
HUB possesses the foundational patent portfolio on organoids and a robust service offering ranging from new model generation to assay development and high-throughput screening, enhancing Merck’s offering of cell culture tools to academia, biotech, and pharma customers. The team of approximately 70 employees is celebrating the acquisition together at the HUB campus in Utrecht, Netherlands.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106594037/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Apollo Group Partners with Oaktree Capital to Facilitate its Next Phase of Growth7.1.2025 23:01:00 CET | Press release
The Apollo Group to Leverage 55-Year Track Record to Provide Award-Winning, Full-Service Hospitality Management Services to the Cruise Industry The Apollo Group (“Apollo” or the “Company”), the leading provider of full-service hospitality management services to the cruise industry, has announced a transformative growth investment from funds managed by Oaktree Capital Management, L.P. ("Oaktree"). Apollo specializes in essential and turnkey hospitality services including crew management, food services, food and beverage distribution, end-to-end procurement and logistics and other related services. This investment will enable Apollo to continue to provide best in class service to its existing customer base while expanding its capabilities in food and beverage distribution. "As we explored potential investment partners, Oaktree stood out because of its hands on approach and storied history of successful investing in F&B and hospitality management companies," said Jose Ramon Barrera, CEO o
Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors7.1.2025 23:00:00 CET | Press release
Collaboration initiates development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs) Biocytogen’s RenLite® meets Acepodia’s AD2C for precision oncology solutions Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107874851/en/ Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors. (Graphic: Business Wire) This collaboration combines Biocytogen’s RenLite® platform with Acepodia’s Antibody-Dual-Drugs Conjugation (AD2C) technology to tackle some of the toughest challenges in oncology—tumor heterogeneity and drug resistance. This novel approach aims to address these complexities by utilizing dual-payloads that target multiple therapeutic or disease pathways. These payl
SPIE, the International Society for Optics and Photonics, Announces Its 2025 Fellows7.1.2025 22:49:00 CET | Press release
The Society is welcoming 47 new Fellow Members from across the globe This year, SPIE, the international society for optics and photonics, welcomes 47 Members as new Fellows of the Society. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107849416/en/ SPIE, the international society for optics and photonics, welcomes 47 new Fellows in 2025. (Graphic: Business Wire) The inductees this year represent high-profile leaders in academia, industry, and government, many of whom are prominen
Stonebranch Universal Connector Achieves SAP® Certified Integration for RISE with SAP S/4HANA® Cloud7.1.2025 17:25:00 CET | Press release
Stonebranch strengthens its partnership with SAP through a certified integration for RISE with SAP S/4HANA Cloud, empowering enterprise automation across hybrid IT environments. Stonebranch, a leading provider of service orchestration and automation solutions, announced today that its Universal Connector for SAP has achieved SAP® certification as integrated with RISE with SAP S/4HANA® Cloud. The integration helps organizations to centrally orchestrate automated workloads across all SAP applications and beyond. "Our longstanding partnership with SAP reflects our commitment to empowering enterprises with sophisticated automation solutions," said Giuseppe Damiani, Stonebranch CEO. "This certification for SAP RISE with SAP S/4HANA Cloud further strengthens our ability to support hybrid IT environments by offering centralized automation and unparalleled observability for mission-critical operations." Available on the SAP Store, the Universal Connector for SAP is a feature-rich direct integr
Cepton Announces Completion of Acquisition by Koito, Ushering in New Era of Long-Term Lidar Deployment7.1.2025 17:10:00 CET | Press release
Strategic partnership to drive full-scale industrialization of lidar technology, with a strong focus on quality, reliability and sustainability The acquisition combines Cepton's cutting-edge lidar technology with Koito's global automotive expertise, paving the way for new advancements in safe autonomy. By joining forces with Koito, Cepton will accelerate the global commercialization of its lidar solutions across automotive and smart infrastructure markets. The integration of Cepton will expand Koito’s business platform, setting industry standards in mass-market lidar adoption for next-generation mobility solutions. Cepton, Inc. (“Cepton” or the “Company”), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced the completion of its acquisition by KOITO MANUFACTURING CO., LTD. (“Koito”) (TSE: 7276), a leading tier one supplier of automotive lighting systems. As a privately held, indirect subsidiary of Koito in the United States, Cepton will continue t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom